Rui-fu Yang - Epidemiology

Author Information

Ruifu Yang is a distinguished researcher affiliated with the State Key Laboratory of Pathogen and Biosecurity at the Beijing Institute of Microbiology and Epidemiology in Beijing, China. His work primarily focuses on microbiology and epidemiology, contributing significantly to our understanding of infectious diseases and their prevention.

Research Contributions

Ruifu Yang has made substantial contributions to the field of epidemiology and microbiology, with a particular focus on infectious diseases. His recent publications cover a wide range of topics, including antibiotic resistance, rapid diagnostic technologies, zoonotic disease origins, and the impact of environmental factors on health. Notably, his research on colistin-resistant hypervirulent Klebsiella pneumoniae, point-of-care assays for COVID-19, and the genomic epidemiology of Vibrio parahaemolyticus provides critical insights into emerging public health threats. Additionally, Yang's work extends to understanding the gut microbiome's role in disease, as evidenced by his studies on altitude-induced cardiac hypertrophy and colorectal cancer.

Aliases

The author is also known by the aliases Ruifu Yang and Rui-fu Yang.

Publication and Citation Metrics

Citation Count	19,993
H-index	59
Paper Count	407

Publications:

Emergence of colistin-resistant hypervirulent Klebsiella pneumoniae (CoR-HvKp) in China

DOI: 10.1080/22221751.2022.2036078

Year: 2022

Development and multi-center clinical trials of an up-converting phosphor technology-based point-of-care (UPT-POCT) assay for rapid COVID-19 diagnosis and prediction of protective effects

DOI: 10.1186/s12866-022-02450-z

Year: 2022

The Animal Origin of Major Human Infectious Diseases: What Can Past Epidemics Teach Us About Preventing the Next Pandemic?

DOI: 10.15212/zoonoses-2021-0028

Year: 2022

Alterations in gut microbiota and metabolites associated with altitude-induced cardiac hypertrophy in rats during hypobaric hypoxia challenge.

DOI: 10.1007/s11427-021-2056-1

Year: 2022

Large-scale genomic epidemiology reveals the cryptic outbreaks, hidden persistent reservoirs, and spatiotemporal dynamics of Vibrio parahaemolyticus

DOI: 10.21203/rs.3.rs-1255817/v1

Year: 2022

Small Insertions and Deletions Drive Genomic Plasticity during Adaptive Evolution of Yersinia pestis

DOI: 10.1128/spectrum.02242-21

Year: 2022

Evaluation of pathogenesis and biofilm formation ability of Yersinia pestis after 40-day exposure to simulated microgravity

DOI: 10.1017/s1473550422000039

Year: 2022

Metagenomics analysis of cultured mucosal bacteria from colorectal cancer and adjacent normal mucosal tissues.

DOI: 10.1099/jmm.0.001523

Year: 2022

Gut Microbiome-Targeted Modulations Regulate Metabolic Profiles and Alleviate Altitude-Related Cardiac Hypertrophy in Rats

DOI: 10.1128/spectrum.01053-21

Year: 2022

Issue Information‐ToC

DOI: 10.1002/jcp.29855

Year: 2021

What is the European Food Safety Authority (EFSA)?

What Are Common Sources of Epidemiological Data?

How is Crash Severity Measured?

Who is a Research Director in Epidemiology?

What are Molecular Adjuvants?

How is Non-Adherence Measured and Monitored?

What Is the Role of Epidemiology in Cardiovascular Health?

Why is GLASS Important?

What is Uterine Prolapse?

Why is Diagnostic Stewardship Important?

Partnered Content Networks

Relevant Topics